Taking Wegovy every other week: what the evidence actually says

You've missed a week and you're wondering whether to just stretch it out

It happens. The pen is still in the fridge door, you had a busy fortnight, or you are trying to make a box last longer because the cost is on your mind. Whatever the reason, this question usually comes from a genuinely practical place, not a lack of commitment to treatment.

Here is the honest answer: Wegovy is licensed and clinically studied as a once-weekly injection. The dosing interval is not arbitrary. Semaglutide has a half-life of approximately seven days, which is precisely why once a week works so well, each injection essentially tops up the previous one, keeping the drug at a therapeutic level in your system. If you are wondering whether taking Wegovy every two weeks is a viable alternative, our guide to using Wegovy every two weeks explains why you are no longer maintaining that steady concentration and instead letting it drop substantially before each injection, which undermines the appetite-suppressing effect the medicine relies on.

The NHS medicines guidance for semaglutide makes clear that the standard schedule should be followed as closely as possible, and the Wegovy Summary of Product Characteristics does not include a fortnightly option as an alternative. Missing a single dose occasionally is different from deciding to use the medicine every other week as a routine.

If you have already gone past seven days since your last injection, the Wegovy patient information leaflet explains when it is safe to take a missed dose versus when to skip it and resume your usual schedule. Your prescriber is the right person to advise for your specific situation.

What actually happens to your weight loss if you use Wegovy every other week

The STEP 1 trial, published in the New England Journal of Medicine, showed an average weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose, taken once weekly without interruption. That evidence base simply does not exist for a fortnightly schedule, because it has not been studied that way in large trials.

What we do know from pharmacology is that semaglutide's appetite-suppressing effect depends on continuous receptor engagement. Patients who stop treatment entirely typically see appetite return within weeks. A fortnightly schedule sits somewhere between continuous treatment and stopping altogether, but closer to the latter in terms of drug levels at the end of each cycle. You might still lose some weight, but you would almost certainly be getting a fraction of the benefit the medicine can offer.

There is also the question of tolerability. Some people reason that spreading doses out would reduce side effects. It might reduce some gastrointestinal symptoms, but it also tends to mean your system never fully adjusts, so the nausea and discomfort can restart with each injection rather than settling as it does on a consistent schedule. If side effects are the real concern, slower titration is a more evidence-based approach, and one worth raising with your prescriber.

For context on what the evidence supports at different dose levels, the prescribing criteria for Wegovy can also help frame whether the medicine is right for your situation.

When a fortnightly interval might not be about convenience at all

Sometimes the question is really about something else. Cost is a common driver: if a pen lasts twice as long, the monthly outlay halves. That is an understandable calculation. For more on what private treatment realistically costs and what a legitimate price should include, the Wegovy cost page sets that out plainly.

Needle anxiety is another factor. Some people find the weekly injection harder to maintain psychologically than the medication itself. If that resonates, it is worth knowing that the Wegovy pen is designed to be straightforward, and many people find the routine becomes unremarkable after a few weeks. A prescriber can talk through injection technique and any anxiety around it.

Supply problems are a third reason people consider stretching doses. Wegovy has faced periods of constrained availability in the UK. If supply is the issue, the clinically correct approach is to contact your prescriber and document any interruption, rather than self-managing a modified schedule in the background.

None of these problems are best solved by adjusting the frequency unilaterally. They are each solvable, differently. If you are exploring whether Wegovy is the right treatment for you at all, understanding the BMI criteria is a good starting point, and our weight-loss treatment overview sets out the options available. The team at nume is available seven days a week for aftercare questions from existing patients, and our contact page has the quickest routes through.

If you want to explore starting treatment or have questions about whether Wegovy suits your circumstances, check your eligibility with a free consultation and a GPhC-registered prescriber will review your case the same day.